Uptravi Drug Interactions
Currently displaying a list of 232 drugs known to interact with Uptravi (selexipag).
- 7 major drug interactions
- 224 moderate drug interactions
- 1 minor drug interaction
Medications known to interact with Uptravi
Note: Showing generic names only.
A
- abametapir topical
- abiraterone
- abrocitinib
- acalabrutinib
- acebutolol
- acetazolamide
- adagrasib
- alfuzosin
- aliskiren
- alprostadil
- amifostine
- amiloride
- amlodipine
- amyl nitrite
- apalutamide
- apomorphine
- apraclonidine ophthalmic
- aprocitentan
- arginine
- asciminib
- atenolol
- azilsartan medoxomil
B
- bempedoic acid
- benazepril
- bendroflumethiazide
- benzthiazide
- bepridil
- betaxolol
- bexagliflozin
- bisoprolol
- brigatinib
- brimonidine ophthalmic
- brimonidine topical
- bumetanide
C
- canagliflozin
- candesartan
- capmatinib
- captopril
- carbamazepine
- carteolol
- carvedilol
- chlorothiazide
- chlorthalidone
- citrulline
- clevidipine
- clonidine
- clopidogrel
- cyclandelate
D
- danicopan
- dapagliflozin
- darolutamide
- deferasirox
- deserpidine
- diazoxide
- dichlorphenamide
- diltiazem
- divalproex sodium
- doxazosin
- duvelisib
E
- elacestrant
- empagliflozin
- enalapril
- enalaprilat
- enasidenib
- encorafenib
- entrectinib
- enzalutamide
- ephedrine
- ephedrine nasal
- epinephrine
- eplerenone
- eprosartan
- erdafitinib
- ertugliflozin
- esmolol
- ethacrynic acid
- ethaverine
F
- felodipine
- fenoldopam
- fexinidazole
- finerenone
- fluconazole
- fosinopril
- fostamatinib
- fostemsavir
- furazolidone
- furosemide
G
H
I
- idelalisib
- indapamide
- irbesartan
- isocarboxazid
- isosorbide
- isosorbide dinitrate
- isosorbide mononitrate
- isoxsuprine
- isradipine
- ivosidenib
L
- labetalol
- lapatinib
- larotrectinib
- lasmiditan
- leniolisib
- letermovir
- levamlodipine
- levoketoconazole
- linezolid
- lisinopril
- lofexidine
- lonafarnib
- lorlatinib
- losartan
M
- ma huang
- mannitol
- maraviroc
- maribavir
- mavorixafor
- mecamylamine
- methazolamide
- methyclothiazide
- methyldopa
- metolazone
- metoprolol
- mibefradil
- midostaurin
- mifepristone
- minoxidil
- minoxidil topical
- moexipril
- momelotinib
N
- nadolol
- nebivolol
- neratinib
- nesiritide
- nicardipine
- nifedipine
- nimodipine
- niraparib
- nisoldipine
- nitroglycerin
- nitroprusside
O
P
- pacritinib
- pamabrom
- papaverine
- pazopanib
- pemigatinib
- penbutolol
- perindopril
- phenelzine
- phenoxybenzamine
- phentolamine
- phenylephrine
- phenylpropanolamine
- phenytoin
- pindolol
- pirtobrutinib
- pitolisant
- polythiazide
- pralsetinib
- prazosin
- probenecid
- procarbazine
- propranolol
- pseudoephedrine
Q
R
- ramipril
- rasagiline
- rauwolfia serpentina
- reserpine
- resmetirom
- ribociclib
- rifampin
- rifapentine
- riociguat
- ripretinib
- rucaparib
S
- safinamide
- sarecycline
- selegiline
- selinexor
- selpercatinib
- sodium nitrite
- sotagliflozin
- sotalol
- sotorasib
- sparsentan
- spironolactone
T
- tadalafil
- tamsulosin
- taurine
- tazemetostat
- tecovirimat
- tedizolid
- telmisartan
- tepotinib
- terazosin
- teriflunomide
- timolol
- tolazoline
- tolvaptan
- torsemide
- trandolapril
- tranylcypromine
- triamterene
- trichlormethiazide
- trimethaphan camsylate
- trimethoprim
- trofinetide
- tucatinib
V
Uptravi alcohol/food interactions
There is 1 alcohol/food interaction with Uptravi (selexipag).
Uptravi disease interactions
There are 2 disease interactions with Uptravi (selexipag) which include:
More about Uptravi (selexipag)
- Uptravi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (25)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: agents for pulmonary hypertension
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.